Expand ENLV Menu
ENLV MENU

ENLV Latest Press Releases

-- June 24, 2026 --

Enlivex Treasury Portfolio Update: Listing of the RAIN Token on Gate, One of the World's Largest Cryptocurrency Exchanges by Spot Trading Volume Globe Newswire 8:00 AM

-- June 22, 2026 --

Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.14 Billion Globe Newswire 8:45 AM

-- June 15, 2026 --

Enlivex Announces Issuance of Australian Patent Covering the Use of Allocetra in Patients with Osteoarthritis Globe Newswire 8:00 AM

-- June 2, 2026 --

ENLIVEX TO PRESENT QUALITY LONGEVITY MODEL POWERED BY PREDICTION MARKETS TREASURY AT PROOF OF TALK 2026 Globe Newswire 8:00 AM

-- June 1, 2026 --

Allocetra Shows Durable 6-Month Efficacy in Knee Osteoarthritis Phase IIa Trial; Oral Presentation at EULAR 2026 Globe Newswire 8:00 AM

-- May 28, 2026 --

Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.16 Billion; Rain Foundation Appoints Industry Leaders to Advisory Board Globe Newswire 8:00 AM

-- May 27, 2026 --

Enlivex Treasury Portfolio Update: Rain Protocol Jumps Into Top Three Global Prediction Markets In League Table Following $100M In Additional Liquidity Globe Newswire 8:00 AM

-- May 18, 2026 --

Enlivex Announces Dosing Of First Patient In The United States As Part Of Its Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis Globe Newswire 8:00 AM

-- May 15, 2026 --

Enlivex Announces Receipt of Nasdaq Minimum Bid Price Notification Globe Newswire 4:10 PM

-- April 30, 2026 --

Enlivex Treasury Portfolio Update: Listing of the RAIN Token on HTX, a Leading Cryptocurrency Exchange Globe Newswire 8:30 AM

-- April 28, 2026 --

Enlivex Treasury Update: Total RAIN Holdings Rise to 78,819,756,062 Tokens as of April 27, 2026, Representing an Aggregated Value of $567 Million Globe Newswire 8:30 AM

-- April 23, 2026 --

Enlivex to Present Phase IIa 3-month and 6-month Data of Allocetra at OARSI 2026 World Congress Globe Newswire 8:30 AM

-- April 21, 2026 --

Enlivex Announces Second Regulatory Approval for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis Globe Newswire 8:30 AM

-- April 8, 2026 --

Ondo Global Markets Tokenizes Enlivex's Ordinary Shares Globe Newswire 8:30 AM

-- March 26, 2026 --

Enlivex Rain Update: Rain Launches an OpenClaw and AI Agent Interface Allowing Anyone To Create A Prediction Market Via A Single Prompt Globe Newswire 8:30 AM

-- March 25, 2026 --

Enlivex Reports Full-Year 2025 Results: Profit (Net Income) of $1.23 Billion and Diluted Earnings Per Share (EPS) of $25.48 Globe Newswire 8:30 AM

-- March 24, 2026 --

Enlivex Announces $21 Million Debt Financing, Decentralized Prediction Markets RAIN Token-Related Updates and $20 Million Share Repurchase Program Globe Newswire 8:30 AM

-- March 23, 2026 --

Quality Longevity Company Enlivex Receives Investigational New Drug (IND) Clearance from the FDA for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis Globe Newswire 8:00 AM

-- February 10, 2026 --

Enlivex Treasury Portfolio Update: New Listing of the RAIN Token on Kraken, the Second-Largest U.S. Cryptocurrency Exchange Globe Newswire 8:00 AM

-- January 26, 2026 --

Enlivex Treasury Portfolio Update: Listing of the RAIN Token on WhiteBIT, a Leading Cryptocurrency Exchange Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes